Loading provider…
Loading provider…
Hematology & Oncology Physician in Duarte, CA
NPI: 1164470126Primary Employer
City of Hope Medical - San Bernardino Radiation Oncology
cityofhope.org
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2011 - 2027
NC State Medical License
2021 - 2022
NY State Medical License
2009 - 2013
MA State Medical License
2004 - 2011

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Memorial Sloan Kettering Cancer Center
Fellowship • Blood & Bone Marrow Transplant
2009 - 2011
Boston University Medical Center
Fellowship • Hematology and Medical Oncology
2006 - 2009
Residency • Internal Medicine
2001 - 2004
College of Medicine - Tucson
medicine.arizona.edu
Medical School
Until 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 124 | 291 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 109 | 177 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 34 | 169 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 17 | 20 |
Immunological memory and acquired immunodeficiency syndrome pathogenesis.
Authors: Kaur, A, Rosenzweig, M, Johnson, R P
Journal: Philos Trans R Soc Lond B Biol Sci
Treatment of Multiple Myeloma: Finding the Right Combination.
Authors: Rosenzweig, Michael A, Krishnan, Amrita
Journal: Oncology (Williston Park)
Authors: Rosenzweig, M, Pykett, M, Marks, D F, Johnson, R P
Journal: Gene Ther
Lead Sponsor: Mayo Clinic
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Ixazomib Citrate, DRUG: Dexamethasone, DRUG: Idasanutlin
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Leflunomide
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Dexamethasone, DRUG: Pomalidomide, DRUG: Leflunomide